Evidence map›Paper›PMID 31440812›Full record

ArticleRheumatology international2019

Characteristics of patients with giant cell arteritis who experience visual symptoms.

Chung Shen Chean, James A Prior, Toby Helliwell, John Belcher, Sarah L Mackie, Samantha L Hider, Jennifer Liddle, Christian D Mallen

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Rheumatology international, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Ultrasound for the Diagnosis of Giant Cell Arteritis.European journal of rheumatology · 2024
    Article
  6. Review
  7. Article
  8. Article
  9. Giant cell arteritis.British dental journal · 2021
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Chung Shen CheanSchool of Primary, Community and Social Care, Keele University, David Weatherall Building, Keele, ST5 5BG, UK.ORCID http://orcid.org/0000-0002-1625-4078
James A PriorSchool of Primary, Community and Social Care, Keele University, David Weatherall Building, Keele, ST5 5BG, UK. j.a.prior@keele.ac.uk.ORCID http://orcid.org/0000-0001-9213-2796
Toby HelliwellSchool of Primary, Community and Social Care, Keele University, David Weatherall Building, Keele, ST5 5BG, UK.ORCID http://orcid.org/0000-0003-3987-6045
John BelcherResearch and Innovation, Wythenshawe Hospital, Manchester University Foundation Hospital Trust, Manchester, UK.ORCID http://orcid.org/0000-0001-6844-0932
Sarah L MackieLeeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.ORCID http://orcid.org/0000-0003-2483-5873
Samantha L HiderSchool of Primary, Community and Social Care, Keele University, David Weatherall Building, Keele, ST5 5BG, UK.ORCID http://orcid.org/0000-0002-9958-3909
Jennifer LiddleInstitute of Health and Society, Newcastle University, Newcastle upon Tyne, UK.ORCID http://orcid.org/0000-0003-1059-1230
Christian D MallenSchool of Primary, Community and Social Care, Keele University, David Weatherall Building, Keele, ST5 5BG, UK.ORCID http://orcid.org/0000-0002-2677-1028

Funding

Department of Health NIHR-CS-012-016Medical Research Council MR/N011775/1National Institute for Health Research NIHR-RP-2014-04-026National Institute for Health Research School for Primary Care Research 294
6 · The paper itself

Abstract

Permanent vision loss is one of the most serious complications of giant cell arteritis (GCA) and therefore prompt diagnosis is paramount. However, diagnosis of GCA remains challenging due to its frequently non-specific presentation. Our aim was to identify differences in the characteristics of GCA patients with, and without, current visual symptoms. A cross-sectional survey was mailed to patients with a GCA Read code entered in their GP electronic medical record. Responders were categorised as those currently reporting a visual symptom or not. We compared general and GCA-specific characteristics in these two groups. The association of diagnostic delay with subsequent experience of visual symptoms was examined using unadjusted and adjusted linear regression analysis. 318 GCA patients responded to the survey (59.6%). Responders were predominantly female (69.8%), with a mean age of 73.7 years (SD 8.2). 28% reported current visual symptoms. There was no statistically significant difference in the general characteristics between those with and without visual symptoms. Of GCA-specific characteristics, pre-GCA diagnosis of diplopia (p = 0.018), temporary (p ≤ 0.001) or permanent visual problems (p = 0.001) and hoarseness (p = 0.004) were more common among those reporting current visual symptoms. There was no association between the extent of diagnostic delay and reporting of current visual symptoms. Though we found few characteristics to distinguish between GCA patients with or without current visual symptoms, diagnostic delay was not associated with current visual symptoms. Our findings highlighted the continued difficulty for clinicians to identify GCA patients at the highest risk of visual complications.

Indexed as

Vision, OcularAgedAged, 80 and overCross-Sectional StudiesDelayed DiagnosisDisease ProgressionEarly DiagnosisEnglandFemaleGiant Cell ArteritisHealth SurveysHumansMalePredictive Value of TestsPrevalencePrognosisDiagnostic delayGiant cell arteritisVisual symptoms

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.